A groundbreaking shift in Canadian drug policy has taken place, as the authorities announce the legalization of psilocybin hallucinogens for therapeutic treatment. Until now, these substances were heavily restricted, but a increasing body of evidence suggests they potentially offer aid for emotional issues like depression. This development represen